Drug Shortage Report for PENICILLIN G SODIUM FOR INJECTION, USP
| Report ID | 238762 |
| Drug Identification Number | 02220288 |
| Brand name | PENICILLIN G SODIUM FOR INJECTION, USP |
| Common or Proper name | PENICILLIN G SODIUM FOR INJECTION, USP |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | PENICILLIN G |
| Strength(s) | 5000000UNIT |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 15 mL |
| ATC code | J01CE |
| ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-08-02 |
| Estimated end date | 2025-01-31 |
| Actual end date | 2025-01-31 |
| Shortage status | Resolved |
| Updated date | 2025-02-28 |
| Company comments | Fresenius Kabi Canada regrets to advise that due to further production delays, we will be extending the backorder on our Penicillin G Sodium for Injection, USP 5 million units SD Vial 15 mL until January 31, 2025. During this time, our Penicillin G Sodium for Injection, USP 10 million units SD Vial 50 mL will remain available as a substitute. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2025-02-28 | French | Compare |
| v3 | 2025-02-28 | English | Compare |
| v2 | 2024-09-27 | French | Compare |
| v1 | 2024-09-27 | English | Compare |
Showing 1 to 4 of 4